-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ral8mOW6YhMSkXAVxdzIb9n+VkdU4Ze2+KGNAhlyuULvAQlbIcZGr1+u9DYO2H8e AJ//1HUUK/E6gV623iO8MA== 0001381825-09-000006.txt : 20091112 0001381825-09-000006.hdr.sgml : 20091111 20091112162951 ACCESSION NUMBER: 0001381825-09-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091112 DATE AS OF CHANGE: 20091112 EFFECTIVENESS DATE: 20091112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELL BIOSCIENCES INC CENTRAL INDEX KEY: 0001381825 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-96789 FILM NUMBER: 091177452 BUSINESS ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 BUSINESS PHONE: 408 510-5500 MAIL ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0603 D LIVE 0001381825 CELL BIOSCIENCES INC 3040 OAKMEAD VILLAGE DRIVE CUPERTINO CA 94304 408 510-5500 DELAWARE None None Corporation true Timothy Harkness c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Executive Officer Director David Barker c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Director James Blair c/o Domain Associates One Palmer Square, Suite 515 Princeton NJ 08542 Director A. Blaine Bowman c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Director Julie Eskay-Eagle c/o The Wellcome Trust Gildos Building, 215 Euston Road London X0 NW1 2BE Director Jack Nielson c/o Novo A/S Krogshoejvej 41 Bagsvaerd G7 DK 2880 Director James Woody c/o Latterell Venture Partners 1 Embarcadero Center, Suite 4050 San Francisco CA 94111 Director James Novi c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA 95051 Executive Officer Biotechnology Decline to Disclose 06 false 2009-10-29 false true true true true Offering of Series D Preferred Stock (the "Series D"), warrants to purchase Common Stock (the "Warrants") and the underlying shares of Common Stock issuable upon exercise of Warrants and upon conversion of the Series D. false 0 17642029 15018337 2623692 Includes the aggregate exercise price of Warrants (as defined in Item 9) false 10 0 0 0 false CELL BIOSCIENCES INC /s/ Timothy Harkness Timothy Harkness President and CEO 2009-11-11 -----END PRIVACY-ENHANCED MESSAGE-----